Capricor Therapeutics
Biotechnology, Road to the Cure Ste 150, San Diego, , 92121, California, 10865, United States, 51-200 Employees
Phone Number: 31********
Who is CAPRICOR THERAPEUTICS
Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients lives. Caprico...
Read More
-
Headquarters: 10865 Road to the Cure Ste 150, San Diego, California, 92121, United States
-
Date Founded: 2005
-
Employees: 51-200
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
-
CEO:
Linda Marban
Email
Phone
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from CAPRICOR THERAPEUTICS
Capricor Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Capricor Therapeutics
Answer: Capricor Therapeutics's headquarters are located at Road to the Cure Ste 150, San Diego, , 92121, California, 10865, United States
Answer: Capricor Therapeutics's phone number is 31********
Answer: Capricor Therapeutics's official website is https://capricor.com
Answer: Capricor Therapeutics's revenue is $1 Million to $5 Million
Answer: Capricor Therapeutics's SIC: 2834
Answer: Capricor Therapeutics's NAICS: 325412
Answer: Capricor Therapeutics has 51-200 employees
Answer: Capricor Therapeutics is in Biotechnology
Answer: Capricor Therapeutics contact info: Phone number: 31******** Website: https://capricor.com
Answer: Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients lives. Capricor is focused on the development of biologics, primarily cell and exosome-based technologies to treat or prevent a broad range of diseases. Our lead product is a cell therapy designed to treat Duchenne muscular dystrophy (DMD), the most severe form of muscular dystrophy, which results in muscle degeneration and premature death. Capricors innovative exosome technology is focusing on engineering exosomes to treat or prevent diseases with high unmet medical needs. Our translational approach to product development is based on the strong research foundation provided by our academic partnerships with leading scientists at top-tier research institutions.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month